Genomic Biomarkers
Genomic biomarkers are measurable genetic indicators that help reveal an individual’s risk of disease, response to treatment, or likelihood of experiencing adverse drug reactions. These biomarkers include gene mutations, copy number variations, expression profiles, and epigenetic signatures that provide valuable insights into underlying biological mechanisms. By identifying specific genomic patterns, clinicians can diagnose diseases earlier, classify subtypes more accurately, and tailor therapies to match a patient’s molecular profile. Genomic biomarkers have become essential tools in oncology, cardiovascular medicine, neurology, and metabolic disorders, enabling precise prediction of therapeutic outcomes. Their role extends to monitoring disease progression, evaluating treatment effectiveness, and guiding personalized prevention strategies.
Article Processing Timeline
| 2-5 Days | Initial Quality & Plagiarism Check |
| 25-35 Days |
Peer Review Feedback |
| 45-60 Days | Total article processing time |
Why Publish with us?
Ethics & Policies
Editorial & Management
Useful Links
Journal Highlights
Open Access Journals
Membership
Journal Flyer
